209 related articles for article (PubMed ID: 34146582)
1. A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis.
Hou S; Niu G; Liu X; Bourbon PM; Zhang D; Cui P; Zhao K; Zhao D; Zeng H
Microvasc Res; 2021 Nov; 138():104209. PubMed ID: 34146582
[TBL] [Abstract][Full Text] [Related]
2. Down Syndrome Candidate Region 1 Isoform 1L regulated tumor growth by targeting both angiogenesis and tumor cells.
Chen C; Cui P; Zhao K; Niu G; Hou S; Zhao D; Zeng H
Microvasc Res; 2022 Mar; 140():104305. PubMed ID: 34958805
[TBL] [Abstract][Full Text] [Related]
3. The novel axis of YAP1, transcription enhancer factor 3 and Down Syndrome Candidate Region 1 isoform 1L is a common signaling pathway downstream of several angiogenic factors.
Cui P; Liu X; Zhao K; Hou S; Chen C; Zhao D; Zeng H
Microvasc Res; 2020 May; 129():103955. PubMed ID: 31733305
[TBL] [Abstract][Full Text] [Related]
4. Transcription enhancer factor 3 (TEF3) mediates the expression of Down syndrome candidate region 1 isoform 1 (DSCR1-1L) in endothelial cells.
Liu X; Zhao D; Qin L; Li J; Zeng H
J Biol Chem; 2008 Dec; 283(49):34159-67. PubMed ID: 18840614
[TBL] [Abstract][Full Text] [Related]
5. Down syndrome candidate region 1 isoform 1 mediates angiogenesis through the calcineurin-NFAT pathway.
Qin L; Zhao D; Liu X; Nagy JA; Hoang MV; Brown LF; Dvorak HF; Zeng H
Mol Cancer Res; 2006 Nov; 4(11):811-20. PubMed ID: 17114339
[TBL] [Abstract][Full Text] [Related]
6. Requirement of the nuclear localization of transcription enhancer factor 3 for proliferation, migration, tube formation, and angiogenesis induced by vascular endothelial growth factor.
Liu X; Zhao D; James L; Li J; Zeng H
FASEB J; 2011 Apr; 25(4):1188-97. PubMed ID: 21169383
[TBL] [Abstract][Full Text] [Related]
7. Down syndrome candidate region 1-like 1 (DSCR1-L1) mimics the inhibitory effects of DSCR1 on calcineurin signaling in endothelial cells and inhibits angiogenesis.
Gollogly LK; Ryeom SW; Yoon SS
J Surg Res; 2007 Sep; 142(1):129-36. PubMed ID: 17610901
[TBL] [Abstract][Full Text] [Related]
8. A single extra copy of Dscr1 improves survival of mice developing spontaneous lung tumors through suppression of tumor angiogenesis.
Shin J; Lee JC; Baek KH
Cancer Lett; 2014 Jan; 342(1):70-81. PubMed ID: 24051307
[TBL] [Abstract][Full Text] [Related]
9. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of mini-TyrRS-induced angiogenesis response in endothelial cells by VE-cadherin-dependent mini-TrpRS.
Zeng R; Chen YC; Zeng Z; Liu XX; Liu R; Qiang O; Li X
Heart Vessels; 2012 Mar; 27(2):193-201. PubMed ID: 21442253
[TBL] [Abstract][Full Text] [Related]
11. SOX7 suppresses endothelial-to-mesenchymal transitions by enhancing VE-cadherin expression during outflow tract development.
Jiang X; Li T; Li B; Wei W; Li F; Chen S; Xu R; Sun K
Clin Sci (Lond); 2021 Mar; 135(6):829-846. PubMed ID: 33720353
[TBL] [Abstract][Full Text] [Related]
12. VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
Yao YG; Duh EJ
Biochem Biophys Res Commun; 2004 Aug; 321(3):648-56. PubMed ID: 15358155
[TBL] [Abstract][Full Text] [Related]
13. Gastric cancer-secreted exosomal X26nt increases angiogenesis and vascular permeability by targeting VE-cadherin.
Chen X; Zhang S; Du K; Zheng N; Liu Y; Chen H; Xie G; Ma Y; Zhou Y; Zheng Y; Zeng L; Yang J; Shen L
Cancer Sci; 2021 May; 112(5):1839-1852. PubMed ID: 33205567
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylase inhibitors interfere with angiogenesis by decreasing endothelial VEGFR-2 protein half-life in part via a VE-cadherin-dependent mechanism.
Hrgovic I; Doll M; Pinter A; Kaufmann R; Kippenberger S; Meissner M
Exp Dermatol; 2017 Feb; 26(2):194-201. PubMed ID: 27487811
[TBL] [Abstract][Full Text] [Related]
15. Histone acetyltransferase p300 promotes MRTF-A-mediates transactivation of VE-cadherin gene in human umbilical vein endothelial cells.
Shu XZ; Zhang LN; Zhang R; Zhang CJ; He HP; Zhou H; Wang N; Zhang TC
Gene; 2015 May; 563(1):17-23. PubMed ID: 25746323
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-22 regulates inflammation and angiogenesis via targeting VE-cadherin.
Gu W; Zhan H; Zhou XY; Yao L; Yan M; Chen A; Liu J; Ren X; Zhang X; Liu JX; Liu G
FEBS Lett; 2017 Feb; 591(3):513-526. PubMed ID: 28112401
[TBL] [Abstract][Full Text] [Related]
17. Secretion of Down Syndrome Critical Region 1 Isoform 4 in Ischemic Retinal Ganglion Cells Displays Anti-Angiogenic Properties Via NFATc1-Dependent Pathway.
Xu Y; Yang B; Hu Y; Lu L; Lu X; Wang J; Shu Q; Cheng Q; Yu S; Xu F; Huang J; Liang X
Mol Neurobiol; 2017 Oct; 54(8):6556-6571. PubMed ID: 27734335
[TBL] [Abstract][Full Text] [Related]
18. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
19. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
[No Abstract] [Full Text] [Related]
20. The neuronal transcription factor NPAS4 is a strong inducer of sprouting angiogenesis and tip cell formation.
Esser JS; Charlet A; Schmidt M; Heck S; Allen A; Lother A; Epting D; Patterson C; Bode C; Moser M
Cardiovasc Res; 2017 Feb; 113(2):222-223. PubMed ID: 28082451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
